The person, whose identity has not been revealed, may have been exposed to the virus in Democratic Republic of Congo and is now at the University of Nebraska Medical Center.
The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.
As cases ramp up in Democratic Republic of Congo, the government has banned housing Ebola victims and promises police escorts for health workers at burials.